Table 2 Clinical characteristics of DSA-positive recipients

¹

⁴⁴

^Male

^{IgA nephropathy}

^Compatible

^With

^275 months

^DR13

^DQ6

¹¹²²⁶

¹⁹⁰⁵⁶

^Protocol

^cABMR

^AZA→MMF

^{Alive with graft function}

²

⁴³

^Male

^{Chronic glomerulonephritis}

^Compatible

^Without

^252 months

^DQ6

²⁰⁸⁶⁶

^{Serum Cr↑}

^cABMR+

^CNI

^{Steroid pulse, PE, IVIG, Rit, mTOR}

^{Alive with graft function}

³

⁴⁸

^Male

^{Chronic glomerulonephritis}

^Compatible

^Without

^251 months

^DR53

²¹⁵⁶⁶

^Protocol

^cABMR

^{AZA→MMF, steroid pulse}

^{Alive with graft loss}

⁴

⁶¹

^Female

^{Unknown disease}

^Compatible

^With

^142 months

^DR53

^DQ4

^DQ9

²²⁸⁵⁰

²¹⁸⁰³

²¹⁵³⁰

^{Serum Cr↑}

^cABMR

^{Steroid pulse, PE, IVIG, Rit, mTOR}

^{Alive with graft loss}

⁵

⁵⁴

^Female

^ADPKD

^Compatible

^Without

^141 months

^DQ7

⁷²⁴⁶

^Protocol

^{Not definition for cABMR}

^{Steroid pulse, PE, IVIG}

^{Alive with graft function}

⁶

⁵³

^Male

^Sarcoidosis

^Compatible

^Without

⁸⁸

^months

^DR53

³³²⁶

^Protocol

^{nothing particular}

⁻

^{Alive with graft function}

⁷

⁴⁴

^Male

^{IgA nephropathy}

^Compatible

^Without

⁵²

^months

^DR51

¹⁵⁰⁵⁶

^{Serum Cr↑}

^{Proteinuria↑}

^IgA+

^cABMR

^{Steroid pulse, PE, IVIG, Rit}

^{Alive with graft function}

⁸

⁷⁷

^Male

^{IgA nephropathy}

^Compatible

^Without

¹⁸

^months

^DQ7

¹⁴⁹¹⁵

^{Serum Cr↑}

^{Borderline change}

^{rATG, steroid pulse, PE, IVIG}

^{Alive with graft function}